Back
The Eastern Vs. Avidity Biosciences Industry Stock Comparison
Sell
38
EML
The Eastern
Last Price:
$26.62
Seasonality Move:
4.23%
Sell
32
RNA
Avidity Biosciences
Last Price:
$31.10
Seasonality Move:
-10.33%
Sell
38
The Eastern (EML)
is a Sell
Is The Eastern a Buy, Sell or Hold?
-
The current The Eastern [EML] share price is $26.62. The Score for EML is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
EML is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy, Sell or Hold?
-
The current Avidity Biosciences [RNA] share price is $31.11. The Score for RNA is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
RNA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EML Stock Price Chart
What is The Eastern's stock price today?
-
The The Eastern share price today is $26.62Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EML is experiencing selling pressure, which indicates risk of future bearish movement.
RNA Stock Price Chart
What is Avidity Biosciences's stock price today?
-
The Avidity Biosciences share price today is $31.11The current trend is relatively stagnant and RNA is experiencing selling pressure, which indicates risk of future bearish movement.
EML Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.18 | Sell |
Relative Strength Index (14 RSI): | 43.89 | Sell |
Chaikin Money Flow: | -6494 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.72 - 28.4) | Sell |
Bollinger Bands (100): | (26.58 - 30.32) | Sell |
RNA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.26 | Sell |
Relative Strength Index (14 RSI): | 50.29 | Buy |
Chaikin Money Flow: | -1147153 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.65 - 33.51) | Sell |
Bollinger Bands (100): | (29.36 - 43.08) | Sell |
EML Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.11 | Sell |
20-day SMA: | 27.77 | Sell |
50-day SMA: | 27.31 | Sell |
200-day SMA: | 28.71 | Sell |
8-day EMA: | 27.14 | Sell |
20-day EMA: | 27.42 | Sell |
50-day EMA: | 27.67 | Sell |
200-day EMA: | 27.99 | Sell |
RNA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.52 | Buy |
20-day SMA: | 30.84 | Buy |
50-day SMA: | 30.96 | Buy |
200-day SMA: | 38.59 | Sell |
8-day EMA: | 30.94 | Buy |
20-day EMA: | 30.97 | Buy |
50-day EMA: | 32.16 | Sell |
200-day EMA: | 34 | Sell |
The Eastern Earnings Growth & EML Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Avidity Biosciences Earnings Growth & RNA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.28 per share, a decrease next quarter of $0.13 per share, a decrease this year of $0.99 per share, and a decrease next year of $0.57 per share.
The Eastern Technical Analysis
Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Avidity Biosciences Technical Analysis
Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |